Ischemic stroke
Ischemic stroke is a neurological emergency caused by interruption of cerebral blood flow, usually because an artery is occluded by a thrombus, an embolus, or atherosclerotic disease.
Ischemic stroke is a neurological emergency caused by interruption of cerebral blood flow, usually because an artery is occluded by a thrombus, an embolus, or atherosclerotic disease. Reduced perfusion deprives brain tissue of oxygen and glucose, producing an ischemic core of irreversible injury surrounded by a potentially salvageable penumbra. Persistent ischemia can lead to infarct expansion, neurological deficits, disruption of the blood–brain barrier, oxidative stress, inflammation, microglial activation, neuronal injury, and apoptotic processes. Reperfusion may restore blood flow but can also contribute to cerebral ischemia-reperfusion injury and neuroinflammation.
Atrial fibrillation is an important source of cardioembolic ischemic stroke, while diabetes, hypertension, coronary artery disease, and other vascular conditions contribute to cerebrovascular risk. Clinical management focuses on rapid recognition, brain and vascular imaging, restoration of perfusion when appropriate, prevention of recurrent embolism or thrombosis, and rehabilitation. Oral anticoagulants are central to prevention in many patients with atrial fibrillation, although ischemic stroke or transient ischaemic attack can occur despite treatment. Outcomes may also be influenced by age, socioeconomic status, infarct volume, the affected vascular territory—such as the middle cerebral artery—and the severity of the initial neurological deficits.
Rebuilt from PubMed 7 Sept 2026 · no new papers today
Where the papers sit
9 papers study ischemic stroke directly. Those 9 are one subject: Stroke Epidemiology and Care. Risk, diagnosis, treatment intensity and outcomes recur across stroke research, spanning atrial fibrillation, anticoagulation, vaccination and social disadvantage. The work remains descriptive rather than converging on one intervention. No way of splitting those 9 scores better than chance. 1 paradigm shift follows.
Breakthrough ischemic stroke during anticoagulation is not treated as a single anticoagulation failure
The mechanisms of ischemic stroke and transient ischemic attack despite oral anticoagulation in atrial fibrillation, and the outcomes of breakthrough ischemic stroke with competing etiologies after oral anticoagulation, instead frame these events as potentially arising from multiple stroke mechanisms rather than from one uniform failure of anticoagulation. This changes the implication of a stroke occurring during anticoagulant treatment: management and prognosis may depend on identifying the underlying competing etiology, not simply intensifying or switching anticoagulation 42275655Jun 41974022Apr.
Recent Findings on ischemic stroke
Studies in this cluster address atrial fibrillation–associated ischemic stroke through outcome surveillance, anticoagulant recognition, and breakthrough events. The registry found similar major bleeding rates across age groups but higher thromboembolic event rates and mortality among patients aged ≥75 years receiving edoxaban 42455491Jul. Other studies examine mechanisms and competing stroke etiologies after ischemic stroke or transient ischaemic attack despite oral anticoagulation, emphasizing recurrence and bleeding concerns 42275655Jun41974022Apr. Machine learning applied to prothrombin time-International Normalized Ratio and activated partial thromboplastin time targets timely identification of Oral Anticoagulant exposure, while a zero-shot LLM showed strong but context-dependent cardiovascular event retrieval from EMR data 41848031Mar42595369Aug.
The two studies approach ischemic stroke prevention from different directions, combining molecular mechanism analysis with population-level risk reduction. Molecular networking and network pharmacology identified 116 structures in Fangji Dihuang Decoction, including terpenoids, and linked 98 therapeutic targets to AKT1, PTGS2, IL-1B, IL-6, and TNF; Gancao and Guizhi extracts also showed neuroprotective effects with reported EC-50 values 42581834Aug. The cohort study associated seasonal influenza vaccination with a 15% lower risk of incident ischemic stroke among older adults with diabetes, with stronger associations during high antigenic similarity epidemic periods and among patients with coronary heart disease 42522413Jul. The findings support further testing of both the proposed inflammatory mechanisms and the vaccine association, because the latter remains observational and the former relies on predicted targets and pathway analyses.
These studies examine how social position relates to acute stroke care and functional outcomes, but they provide limited evidence about long-term recovery. In Ontario, immigrants with ischemic stroke had similar ICU admission odds but longer ICU stays than long-term residents, alongside lower rates of reperfusion treatments and higher rates of life-sustaining treatments 42685298Sep. The longer ICU stays persisted among patients who did not receive reperfusion treatments and varied across some immigrant subgroups, including refugees and people from Africa, East Asia, and the Middle East 42685298Sep. The Ulaanbaatar study similarly evaluates socioeconomic status against short- and long-term functional outcome, but its abstract does not report the results 42089170May.
Written from 9 PubMed abstracts, each one cited by PMID above. Published: 2026-09-02. Last written: 2026-09-04 by GPT. Drafted by language models from published abstracts; not medical advice.